Eurazeo SE Stock Faces Pressure Amid Negative Earnings Outlook for 2025

Eurazeo SE stock (ISIN: FR0000121121) has declined sharply, down over 7% in the past week and 41% over the past year, as analysts forecast a net loss per share for 2025 despite strong dividend yield projections.

Eurazeo SE stock (ISIN: FR0000121121), the Paris-listed investment holding company, is under significant pressure as it trades near multi-year lows around 41.66 euros as of March 15, 2026. The shares have shed 7.01% over the past five trading days, reflecting broader concerns over a projected net loss per share of -1.68 euros for 2025, even as analysts anticipate a rebound to 6.93 euros in 2026. This dichotomy underscores the holding company's sensitivity to portfolio valuations and asset management performance in a volatile European private equity landscape.

As of: 15.03.2026

By Elena Voss, Senior European Holding Companies Analyst - Tracking NAV discounts and capital allocation strategies in DACH-linked investment vehicles.

Current Market Snapshot: Sharp Weekly Decline Signals Oversold Conditions

The **Eurazeo SE stock** closed at 41.66 euros on March 13, with intraday trades on March 15 confirming levels around 41.66 euros amid thin late-session volume. Over the past week, the stock fell from 44.80 euros on March 9 to 41.66 euros, a 7.01% drop, driven by heightened selling pressure on March 11 when it plummeted 11.61% to 39.74 euros. Moving averages paint a bearish picture: the 20-day at 46.44 euros, 50-day at 49.07 euros, and 100-day at 52.00 euros, all well above current levels, while the RSI14 at 26.90 indicates oversold territory.

Year-to-date, the shares are down 21.84% from January 1 highs of 53.80 euros, with longer-term declines even steeper: 41.03% over one year from peaks near 73 euros, and 34.96% over three years. Order book data shows bids clustered around 40.40-41.30 euros and offers at 42.44-43.40 euros, suggesting limited immediate upside without fresh catalysts.

For European investors, particularly those in Germany tracking Xetra-traded equivalents, this positions Eurazeo as a high-yield value play amid eurozone private equity headwinds, but with NAV discount widening risks.

Analyst Consensus Points to Recovery Potential Despite 2025 Loss

Analysts maintain a positive stance on Eurazeo SE stock, with a consensus target price of 71.88 euros implying 72.53% upside from current levels as of March 14, 2026. The rating skews towards 'Buy' (score 2.00 on a 1-5 scale), supported by projected dividend growth: 2.92 euros per share for 2025 (6.40% yield), rising to 3.26 euros in 2026 (7.14%) and 3.57 euros in 2027 (7.81%). Earnings forecasts show a stark turnaround from -1.68 euros EPS in 2025 to 6.93 euros in 2026 (PER 6.58) and 9.42 euros in 2027 (PER 4.84).

This outlook reflects Eurazeo's dual business model as a holding company: direct portfolio investments (contributing to ANR or adjusted net assets) and fee-related earnings (FRE) from asset management. Forum discussions highlight an ANR per share of 116 euros at end-2025, netting to 102 euros after debt adjustments, plus 31 euros from FRE at a 13x multiple, suggesting a substantial NAV discount at current prices.

From a DACH investor perspective, where holding structures like Eurazeo resonate with investors in companies such as Investor AB or Exor, the high yield and low PER forward make it attractive for income-focused portfolios amid ECB rate cut expectations.

Eurazeo's Holding Model: NAV Logic and Portfolio Exposure

As a leading European investment holding, Eurazeo SE (ISIN: FR0000121121) manages a diversified portfolio across private equity, real assets, and growth capital, with NAV per share as the core valuation metric. The structure trades at a discount to its adjusted net asset value (ANR), currently estimated around 116 euros per share at December 31, 2025, implying over 60% discount at 41.66 euros. This discount has widened amid market volatility, but historical patterns show compression during recovery phases.

Key drivers include portfolio company performance in sectors like consumer goods, technology, and infrastructure. Fee-related earnings from managing third-party funds provide stable cash flows, estimated to add significant value when applying typical 13x multiples to FRE. Capital allocation focuses on buybacks, dividends, and selective acquisitions, with the projected yield progression signaling commitment to shareholders.

For English-speaking investors eyeing European holdings, Eurazeo's Paris HQ and Euronext listing offer liquid exposure to private markets without direct illiquid investments, appealing to DACH funds diversifying beyond Deutsche Boerse blue-chips.

Recent Trading Volatility: What Drove the March Selloff?

The sharp 11.61% drop on March 11, with volume spiking to 568,539 shares, likely stemmed from broader sector rotation out of financials and holdings amid eurozone economic data. Subsequent rebounds of 2.37% on March 12 and 2.41% on March 13 indicate bargain hunting, but failure to reclaim 44 euros resistance keeps downside risks alive. Lows hit 39.22 euros, near the one-month bottom, testing long-term support around 35.60 euros from 10-year history.

European context matters: With ECB policy divergence from the Fed, holding companies like Eurazeo face mark-to-market pressures on unlisted assets, amplified for DACH investors sensitive to euro strength against the Swiss franc.

Dividend Appeal Strengthens for Yield-Hungry Investors

At a prospective 6.40% yield for 2025 rising to 7.81% by 2027, Eurazeo stands out in a low-yield European environment. This is underpinned by consistent payout history and FRE stability, crucial for holding companies where portfolio volatility can disrupt cash flows. Management's focus on capital returns helps narrow NAV discounts over time.

Compared to peers, Eurazeo's yield exceeds many DACH industrials, positioning it as a defensive pick for Swiss and German income portfolios amid potential rate cuts.

Business Segments and Operating Environment

Eurazeo's portfolio spans private equity (core holdings like Iberchem in ingredients), growth investments, and real assets, with asset management fees providing leverage. End-markets face headwinds from inflation and slowing growth, but diversification mitigates risks. Operating leverage kicks in as FRE grows with AUM, targeting higher multiples on stable earnings.

Cash generation supports dividends and buybacks, with balance sheet strength post-debt adjustments key to sustaining the 102 euros net ANR estimate.

Competition and Sector Context in European PE

In the competitive European private equity space, Eurazeo differentiates via its listed holding structure, offering liquidity versus pure-play GPs like Ardian. Sector tailwinds include dry powder deployment, but risks from higher-for-longer rates pressure valuations.

DACH angle: German institutional investors favor such vehicles for mid-market exposure, aligning with Eurazeo's focus.

Catalysts, Risks, and Outlook

**Catalysts** include Q1 2026 earnings showcasing EPS rebound, portfolio exits narrowing NAV discount, and dividend hikes. **Risks** encompass prolonged economic slowdown hitting portfolio values, widening discounts, and forex volatility for non-euro investors.

Outlook: With 72% upside to targets and oversold RSI, Eurazeo SE stock offers asymmetric reward for patient holders, particularly appealing to European yield seekers.

Disclaimer: Not investment advice. Stocks are volatile financial instruments.